Welcome to our dedicated page for TRAVELERS COMPANIES SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRAVELERS COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRAVELERS COMPANIES's regulatory disclosures and financial reporting.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 22,177,978 shares of Travelers Cos Inc/The common stock, representing 10.19% of the class as of 01/30/2026.
Vanguard reports shared voting power over 2,228,435 shares and shared dispositive power over 22,177,978 shares, with no sole voting or dispositive power. The filing notes an internal realignment on 01/12/2026 under which certain Vanguard subsidiaries are expected to report beneficial ownership separately, and confirms the holdings are in the ordinary course of business without intent to influence control.
An insider plans to sell 55,733 shares of common stock under Rule 144 through Fidelity Brokerage Services on 02/04/2026, with trading on the NYSE. The planned sale has an aggregate market value of 16,424,517.04, compared with 223,063,417 shares outstanding. These shares were acquired by exercising stock options for cash on the same date.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance, reported option exercises and a share sale. On January 23, 2026, he exercised stock options for 4,912 shares at $140.85 and 11,800 shares at $132.58, receiving equivalent amounts of Travelers common stock.
On the same date, he sold 16,712 shares of common stock in a market transaction at a weighted average price of $279.7746, with individual trades ranging from $279.60 to $280.25. After these transactions, he directly owned 6,075.303 shares of common stock and 9,016 stock options.
A holder of common stock in TRV has filed a notice of proposed sale under Rule 144. The filing covers 16,712 common shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $4,675,593.46. The filing notes that 223,063,417 shares of this class were outstanding at the time referenced.
The shares to be sold were recently acquired by exercising stock options granted on 02/06/2018 and 02/04/2020, resulting in acquisitions of 4,912 and 11,800 shares, respectively, both paid in cash on 01/23/2026. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
The Travelers Companies, Inc. filed a Form 8-K to announce that it has released its financial results for the quarter ended December 31, 2025. On January 21, 2026, the company issued a press release describing its quarterly operating results and made a detailed fourth quarter 2025 financial supplement available on its website.
The press release is furnished as Exhibit 99.1 and the financial supplement as Exhibit 99.2. These materials are designated as furnished, not filed, meaning they are not automatically subject to certain liability and incorporation provisions under U.S. securities laws unless specifically referenced in other filings.
The Travelers Companies, Inc. director reported receiving additional deferred common stock units instead of cash fees. On 12/31/2025, the director acquired 150.83 deferred common stock units at a reference price of $290.06 per share, bringing the total directly owned deferred units to 11,457.626.
These deferred common stock units are granted under the company’s Deferred Compensation Plan for Non-Employee Directors and related director compensation plans. Each unit will convert on a one-for-one basis into a share of Travelers common stock when distributions are made. The director can elect to receive distributions in a lump sum or in annual installments, and the total includes 42.719 units added on December 31, 2025 through dividend reinvestment features.
The Travelers Companies, Inc. reported that one of its directors acquired deferred common stock units instead of cash fees. On 12/31/2025, the director received 159.45 deferred common stock units of Travelers common stock at a price of $290.06 per share, bringing the director’s total beneficial holding to 4,531.663 deferred common stock units.
According to the company’s Deferred Compensation Plan for Non-Employee Directors, these units will convert into shares of Travelers common stock on a one-for-one basis at distribution. Distribution occurs, at the director’s election, either in a lump sum or in annual installments. The filing also notes that the total includes 16.52 deferred common stock units acquired on December 31, 2025 through dividend reinvestment features of the directors’ compensation plans.
The Travelers Companies, Inc. executive reports equity disposition and updated holdings. A Form 4 filing shows that an officer of Travelers, serving as EVP and Chief Admin Officer, reported a transaction in the company’s common stock on 11/26/2025. The transaction, coded “G,” involved the disposition of 400 shares of common stock at a stated price of $0.
After this transaction, the reporting person beneficially owns 20,291.577 shares of Travelers common stock in a direct account and 1,702.641 shares through a 401(k) plan. The filing is made by one reporting person and reflects an update to that individual’s ownership position in Travelers stock.
The Travelers Companies, Inc. (TRV) reported an insider stock transaction by its Vice Chairman on a Form 4. On 11/25/2025, the executive exercised stock options to acquire 4,000 shares of common stock at an exercise price of $172.50 per share (coded as an "M" transaction). On the same date, the executive sold 2,000 shares at a weighted average price of $293.505 per share, 1,000 shares at $295, and 1,000 shares at $296 (all coded as "S" for sales).
After these transactions, the executive directly beneficially owned 255,085.534 shares of Travelers common stock. Additional indirect holdings included 1,710.706 shares in a 401(k) plan, 2,256 shares held by a spouse, and 250 shares held in trust for a stepson, with the executive disclaiming beneficial ownership of the spouse and trust shares.
The Travelers Companies, Inc. (TRV) executive reports share transfer. An officer of the company, listed as EVP, Strategic Development & President International, filed a Form 4 for a transaction dated 11/25/2025. The filing shows a Code G transaction, indicating a gift of 520 shares of common stock at a reported price of $0.
Following this transaction, the reporting person beneficially owns 117,596.149 shares of Travelers common stock in direct form and 340.501 shares held indirectly through a 401(k) plan. This is a routine insider ownership update and does not change the company’s overall capital structure.